Duke Cancer Institute
Leading-edge cancer care and research have been a hallmark of Duke Medicine for nearly 40 years. Today, the Duke Cancer Institute continues to build on its national and global reputation as one of the foremost centers for cancer diagnosis, treatment, research, education, and training.
The Duke Cancer Institute provides specialized care to patients, treating every cancer type, with 100 oncology-dedicated, board-certified physicians and 500 clinical staff -- nurses, social workers, nutritionists, and others -- dedicated to cancer.
Since 1993, Duke has ranked among the top centers in the nation for cancer services according to U.S.News & World Report and leader in the southeast.
The Duke Cancer Institute is a single entity -- the first of its kind at Duke -- that brings cancer care and research even closer together. By uniting cancer physicians, researchers, educators, and staff across the medical center, medical school, and health system, the DCI offers unprecedented opportunities for teamwork among the scientists in our labs and caregivers in our hospitals and clinics.
We've found
34 trials
at this facility
Gastroenterology, Musculoskeletal, Oncology Clinical Trial
Updated: 6/21/2013
Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer
Status: Enrolling
Updated: 6/21/2013
Click here to add this to my saved trials
HEAD AND NECK CANCER Clinical Trial
Updated: 12/31/1969
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/22/2016
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients
Status: Enrolling,
Phase
II, III
Updated: 11/22/2016
Click here to add this to my saved trials
Sarcoma, Ewing Clinical Trial
Updated: 12/31/1969
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Updated: 12/31/1969
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
GIST With D842V Mutated PDGFRA Gene Clinical Trial
Updated: 12/31/1969
Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Survivorship Care Plan and Embedded Navigation Tool
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 12/31/1969
Communicating About Sexual Concerns and Dysfunction Effectively (CASCADE) Program
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Adult Solid Tumor, Protocol Specific Clinical Trial
Updated: 12/24/2011
Computer Program in Improving Communication Between Doctors and Patients With Stage IV Cancer
Status: Enrolling
Updated: 12/24/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumor Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
EGFR-mutated NSCLC (Disorder) Clinical Trial
Updated: 12/31/1969
MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Brain Metastases Clinical Trial
Updated: 12/31/1969
A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/7/2011
Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Status: Enrolling
Updated: 12/7/2011
Click here to add this to my saved trials
Brain and Central Nervous System Tumors Clinical Trial
Updated: 4/10/2012
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Status: Enrolling
Updated: 4/10/2012
Click here to add this to my saved trials
Melanoma Clinical Trial
Updated: 12/31/1969
Phase IIB TL + YCWP + DC in Melanoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects With Resected Solid Tumors and in Combination With Pembrolizumab in Subjects With Unresectable Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Renal Cell Carcinoma, Metastatic Clinical Trial
Updated: 9/27/2017
Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Status: Enrolling,
Phase
II
Updated: 9/27/2017
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Calming Alternatives Learned During MRI-Guided Breast Biopsy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sarcoma Clinical Trial
Updated: 6/23/2014
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Status: Enrolling,
Phase
III
Updated: 6/23/2014
Click here to add this to my saved trials
Relapsed or Refractory Lymphoid Malignancies Clinical Trial
Updated: 2/26/2016
A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Status: Enrolling,
Phase
I
Updated: 2/26/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 5/22/2017
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
Status: Enrolling,
Phase
III
Updated: 5/22/2017
Click here to add this to my saved trials
Carcinoma, Renal Cell Clinical Trial
Updated: 12/31/1969
Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
High Grade Glioma, Glioblastoma Clinical Trial
Updated: 12/31/1969
Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Pilot Study Investigating the Effect of Chemotherapy on the Tumoral Immunoprofile of Gynecologic Cancers
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Updated: 12/31/1969
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials